# Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors

> **NCT07058948** · PHASE2 · RECRUITING · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Solid Cancers
- Radiotherapy
- Immune Checkpoint Inhibitor
- Lung Cancer

## Interventions

- **RADIATION:** lattice radiation therapy

## Key facts

- **NCT ID:** NCT07058948
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07058948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07058948, "Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07058948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*